116551004: Phenyltoloxamine citrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Phenyltoloxamine citrate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

203177017 Phenyltoloxamine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

679589015 Phenyltoloxamine citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3013121000052111 fenyltoloxamincitrat sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Phenyltoloxamine citrate	Is a	Ethanolamine derivative histamine receptor antagonist product	false	Inferred relationship	Some
Phenyltoloxamine citrate	Is a	sederande antihistamin	false	Inferred relationship	Some
Phenyltoloxamine citrate	Is a	Phenyltoloxamine (substance)	false	Inferred relationship	Some
Phenyltoloxamine citrate	Has disposition (attribute)	Histamine receptor antagonist (disposition)	true	Inferred relationship	Some
Phenyltoloxamine citrate	Is modification of (attribute)	Phenyltoloxamine (substance)	true	Inferred relationship	Some
Phenyltoloxamine citrate	Is a	Ethanolamine derivative antihistamine	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
klorfeniraminmaleat + fenylefrinhydroklorid + fenyltoloxamincitrat 4 mg/20 mg/50 mg, kapsel med modifierad frisättning	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
klorfeniraminmaleat + fenylefrinhydroklorid + fenyltoloxamincitrat 2,5 mg/5 ml 5 mg/5 ml 7,5 mg/5 ml, vätska	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
acetaminofen + fenyltoloxamincitrat 500 mg/30 mg, kapseltablett	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
acetaminofen + fenyltoloxamincitrat	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
klorfeniraminmaleat + fenylefrinhydroklorid + fenyltoloxamincitrat	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
paracetamol + fenyltoloxamincitrat + salicylamid	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	3
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	3
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has basis of strength substance (attribute)	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has precise active ingredient	False	Phenyltoloxamine citrate	Inferred relationship	Some	2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has precise active ingredient	True	Phenyltoloxamine citrate	Inferred relationship	Some	1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet	Has basis of strength substance (attribute)	True	Phenyltoloxamine citrate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
203177017	Phenyltoloxamine citrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
679589015	Phenyltoloxamine citrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3013121000052111	fenyltoloxamincitrat	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)